These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Hanisch FG; Stadie T; Bosslet K Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084 [TBL] [Abstract][Full Text] [Related]
3. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1. Reis CA; Hassan H; Bennett EP; Clausen H Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613 [TBL] [Abstract][Full Text] [Related]
16. MUC1 glycopeptide epitopes predicted by computational glycomics. Song W; Delyria ES; Chen J; Huang W; Lee JS; Mittendorf EA; Ibrahim N; Radvanyi LG; Li Y; Lu H; Xu H; Shi Y; Wang LX; Ross JA; Rodrigues SP; Almeida IC; Yang X; Qu J; Schocker NS; Michael K; Zhou D Int J Oncol; 2012 Dec; 41(6):1977-84. PubMed ID: 23023583 [TBL] [Abstract][Full Text] [Related]
17. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750 [TBL] [Abstract][Full Text] [Related]
18. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin. Dai J; Allard WJ; Davis G; Yeung KK Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094 [TBL] [Abstract][Full Text] [Related]
19. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope. Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice. Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]